Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/6472 stock hub

TPE/6472 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPE/6472is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
53.2B
Taiwan Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPE/6472
In the news

Latest news · TPE/6472

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.4
P25 12P50 15.5P75 22.5
Trailing P/E18
P25 14.4P50 18P75 31.9
ROE27.5
P25 -16.2P50 0.3P75 9.8
ROIC9.1
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPE/6472 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
234
Groups with data
11
Currency
TWD
Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
Taiwan
Country code
TW
Employees
36
Enterprise value
TWD 68.4B
Exchange
Taiwan Stock Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
TW0006472004
Last refreshed
2026-05-10
Market cap
TWD 53.2B
Price
TWD 419
Price currency
TWD
Sector
Healthcare
Sic
2834
Symbol
tpe/6472
Website
https://www.bora-corp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
5.6%
EV Earnings
22.94x
EV/EBIT
24.08x
EV/EBITDA
17.69x
EV/FCF
19.13x
EV/Sales
3.6x
FCF yield
6.72%
Forward P/E
18.43x
P/B ratio
3.05x
P/E ratio
18.03x
P/S ratio
2.8x
PE Ratio10 Y
27.99x
PE Ratio3 Y
22.04x
PE Ratio5 Y
20.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
17.32%
EBITDA Margin
22.16%
FCF margin
18.8%
Gross margin
41.3%
Gross Profit
TWD 7.9B
Gross Profit Growth
0.8%
Gross Profit Growth Q
-10.49%
Gross Profit Growth3 Y
39.18%
Gross Profit Growth5 Y
62%
Net Income
TWD 3B
Net Income Growth
-22.61%
Net Income Growth Q
-3.87%
Net Income Growth Years
0%
Net Income Growth3 Y
28.9%
Net Income Growth5 Y
38.81%
Pretax Margin
27.76%
Profit Margin
15.68%
Profitable Years
7
ROA
4.56
Roa5y
8.38
ROCE
10.49
ROE
27.46
Roe5y
31.18
ROIC
9.05
Roic5y
19.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
40.59%
Cagr1y
-26.91%
Cagr3y
-6.44%
Cagr5y
29.86%
Div CAGR10
52.94%
Div CAGR3
31.48%
Div CAGR5
58.51%
EPS Growth
-42.08
EPS Growth Q
-70.45
EPS Growth Years
0
EPS Growth3 Y
10.3
EPS Growth5 Y
25.9
FCF Growth
691.04%
FCF Growth3 Y
25.35%
FCF Growth5 Y
162.73%
OCF Growth
359.54%
OCF Growth10 Y
86.13%
OCF Growth3 Y
30.85%
OCF Growth5 Y
90.87%
Revenue Growth
9.11x
Revenue Growth Q
-5.15x
Revenue Growth Years
0x
Revenue Growth3 Y
21.91x
Revenue Growth5 Y
60.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
TWD 0.42
Assets
TWD 44.7B
Cash
TWD 5.1B
Current Assets
TWD 19.3B
Current Liabilities
TWD 13.3B
Debt
TWD 18.2B
Debt EBITDA
TWD 4.22
Debt Equity
TWD 1.04
Debt FCF
TWD 5.1
Equity
TWD 17.5B
Interest Coverage
6.8
Liabilities
TWD 27.2B
Long Term Assets
TWD 25.4B
Long Term Liabilities
TWD 13.9B
Net Cash
TWD -13.1B
Net Cash By Market Cap
TWD -24.6
Net Debt EBITDA
TWD 3.11
Net Debt Equity
TWD 0.75
Net Debt FCF
TWD 3.66
Tangible Book Value
TWD 9.1B
Tangible Book Value Per Share
TWD 71.95
WACC
6.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.45
Inventory Turnover
2.5
Net Working Capital
TWD 6.6B
Quick ratio
1.11
Working Capital
TWD 6B
Working Capital Turnover
TWD 2.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-33.62%
Dividend Growth
16.67%
Dividend Growth Years
5%
Dividend per share
TWD 10
Dividend Years
11
Dividend Yield
2.39%
Ex Div Date
2025-06-20
Last Dividend
TWD 11.67
Payout Frequency
Annual
Payout Ratio
48.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
2,915.63%
1Y total return
-26.9%
200-day SMA
577.4
3Y total return
-18.09%
50-day SMA
445.7
50-day SMA vs 200-day SMA
50under200
5Y total return
269.26%
All Time High
812.6
All Time High Change
-48.44%
All Time High Date
2024-07-16
All Time Low
8.6
All Time Low Change
4,774.93%
All Time Low Date
2017-08-15
ATR
14.09
Beta
0.57
Beta1y
0.36
Beta2y
0.22
Ch YTD
-14.14
High
434
High52
795
High52 Date
2025-08-18
High52ch
-47.3%
Low
412.5
Low52
400
Low52 Date
2026-04-27
Low52ch
4.75%
Ma50ch
-5.99%
Price vs 200-day SMA
-27.44%
RSI
46.98
RSI Monthly
40.69
RSI Weekly
34.66
Sharpe ratio
-0.59x
Sortino ratio
-0.69
Total Return
-31.23%
Tr YTD
-14.14
Tr1m
-0.24%
Tr1w
3.2%
Tr3m
-24.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
TWD 3.3B
Operating Income Growth
-11.18
Operating Income Growth Q
-20.31
Operating Income Growth3 Y
19.66
Operating Income Growth5 Y
70.88
Operating margin
17.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
74,182,193%
Net Borrowing
419,365,000
Shares Insiders
7.66%
Shares Institutions
12.38%
Shares Out
126,988,000
Shares Qo Q
155.34%
Shares Yo Y
33.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

65
MetricValue
Adjusted FCF
TWD 3.5B
Average Volume
821,729.05x
Bv Per Share
121.1
CAPEX
TWD -928.7M
Ch10y
2,532.7
Ch1m
-0.24
Ch1w
3.2
Ch1y
-28.18
Ch3m
-24.91
Ch3y
-21.52
Ch5y
246.5
Ch6m
-32.64
Change
1.21%
Change From Open
0.72
Close
414
Days Gap
0.48
Depreciation Amortization
920,391,000
Dollar Volume
854,259,295
Earnings Date
2026-05-12
EBIT
TWD 3.3B
EBITDA
TWD 4.2B
EPS
TWD 15.81
F Score
5
FCF
TWD 3.6B
FCF EV Yield
5.23x
FCF Per Share
TWD 28.15
Financing CF
-1,376,910,000
Fiscal Year End
December
Founded
2,007
Goodwill
2,664,083,000
Graham Number
269.5913
Graham Upside
-35.66
Income Tax
TWD 829.8M
Investing CF
-3,379,649,000
Is Primary Listing
1
Last Earnings Date
2026-03-11
Last Report Date
2025-12-31
Last Split Date
2025-08-04
Last Split Type
Forward
Lynch Fair Value
TWD 587
Lynch Upside
40.08
Ma150
530.4
Ma150ch
-21.01%
Ma20
414
Ma20ch
1.22%
Net CF
-752,308,000
Next Earnings Date
2026-05-12
Open
416
P FCF Ratio
14.88
P OCF Ratio
11.81
Payment Date
2025-07-11
Position In Range
30.23
Ppne
11,183,144,000
Price Date
2026-05-08
Price EBITDA
TWD 12.63
Ptbv Ratio
5.82
Relative Volume
2.56x
Revenue
19,014,169,000x
SBC By Revenue
0.41x
Share Based Comp
78,623,000
Tax By Revenue
4.36x
Tax Rate
15.72%
Tr6m
-32.64%
Volume
2,038,805
Z Score
2.85
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPE/6472 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.4%
$10.0 annual per share
Payout ratio
+48.6%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+58.5%
5 consecutive years of growth
Total shareholder yield
-31.2%
Next ex-dividend date: 2025-06-20
Performance

TPE/6472 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.9%
S&P 500 1Y: n/a
3Y total return
-18.1%
S&P 500 3Y: n/a
5Y total return
+269.3%
S&P 500 5Y: n/a
10Y total return
+2915.6%
S&P 500 10Y: n/a
Ownership

Who owns TPE/6472?

Insider, institutional, and short-interest positioning.

Institutional ownership
+12.4%
Share of float held by funds and institutions
Insider ownership
+7.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+33.6%
Negative means the company is buying back shares.
Technical

TPE/6472 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.0
Neutral momentum band
Price vs 200-day MA
-27.4%
50/200-day relationship not available
Beta (5Y)
0.57
Less volatile than the market
Sharpe ratio
-0.59
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPE/6472

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/6472 stock rating?

tpe/6472 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/6472 analysis?

The full report lives at /stocks/tpe/6472/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/6472?

The latest report frames tpe/6472 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/6472 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.